ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,049Medicare Part D Prescriptions Filled, Including Refills

Rank: 58 out of 680

$886K Total Retail Price of All Prescriptions

Rank: 109 out of 680

687 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 687 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

39% of this provider’s 687 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,577 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,607 694 S3 1 4
CLONIDINE HCL 842 532 10 2 36
AMLODIPINE BESYLATE 821 612 3 1
KLOR-CON M20 754 501 10 4 61
HYDROCHLOROTHIAZIDE 647 424 5 9
POTASSIUM CHLORIDE 470 279 6 14
ZOLPIDEM TARTRATE 430 183 7 17
METFORMIN HCL 396 255 8 8
PRAVASTATIN SODIUM 379 231 9 10
OMEPRAZOLE 354 235 10 7
ALLOPURINOL 309 200 11 33
ATORVASTATIN CALCIUM 293 232 12 11
METOPROLOL SUCCINATE 291 194 13 13
MELOXICAM 257 168 14 24
CARISOPRODOL 239 37 R 15 83
BUMETANIDE 236 142 16 102
SIMVASTATIN 226 146 17 3
LEVOTHYROXINE SODIUM 214 160 18 2
NEXIUM 213 121 19 16
CRESTOR 209 164 20 25
VERAPAMIL ER 208 152 21 100
FUROSEMIDE 189 136 22 6
LISINOPRIL 188 148 23 5
BENAZEPRIL HCL 180 102 24 40
BENAZEPRIL-HYDROCHLOROTHIAZIDE 178 92 25 164
DIOVAN HCT 156 84 26 55
LOVASTATIN 151 119 27 44
GABAPENTIN 151 69 27 15
DIOVAN 139 75 29 31
PROAIR HFA 139 83 29 67
GLIMEPIRIDE 138 74 31 29
AMLODIPINE BESYLATE-BENAZEPRIL 132 109 32 43
AMOX TR-POTASSIUM CLAVULANATE 131 60 33 124
BYSTOLIC 131 82 33 79
QUINAPRIL HCL 129 93 35 104
LOSARTAN-HYDROCHLOROTHIAZIDE 127 95 36 51
ACETAMINOPHEN-CODEINE 126 78 S3 37 175
CARVEDILOL 122 80 38 23
ALPRAZOLAM 121 68 39 72
PLAVIX 114 100 40 39
CLOPIDOGREL 113 103 41 26
METOPROLOL TARTRATE 113 81 41 12
TAMSULOSIN HCL 112 66 43 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 67 44 37
JANUVIA 108 69 45 60
CIPROFLOXACIN HCL 95 57 46 57
COLCRYS 95 45 46 166
TRAMADOL HCL 94 62 48 18
ALENDRONATE SODIUM 92 92 49 32
DONEPEZIL HCL 92 92 49 27
IBUPROFEN 91 53 51 126
LACTULOSE 88 47 52 92
HYDRALAZINE HCL 88 56 52 71
PANTOPRAZOLE SODIUM 86 34 54 30
ATENOLOL 86 53 54 19
LOSARTAN POTASSIUM 85 55 56 21
INSULIN SYRINGE 82 63 57 86
NAPROXEN 81 42 58 121
LIPITOR 74 55 59 68
METFORMIN HCL ER 73 27 60 54
INDOMETHACIN 72 36 R 61 325
DIGOXIN 70 43 62 58
EXFORGE 70 59 62 151
MUPIROCIN 67 39 64 130
WARFARIN SODIUM 65 56 65 20
CELEBREX 64 54 66 90
GLYBURIDE 63 56 R 67 85
GENERLAC 63 42 67 262
PREDNISONE 62 35 69 50
GLIPIZIDE 61 46 70 63
FLUTICASONE PROPIONATE 60 33 71 41
OXYCODONE HCL-ACETAMINOPHEN 59 27 S2 72 133
LANTUS SOLOSTAR 59 16 72 84
KLOR-CON 10 59 51 72 184
FELODIPINE ER 58 17 75 146
DOXYCYCLINE HYCLATE 57 27 76 95
FLUCONAZOLE 54 15 77 139
LYRICA 51 26 78 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.